Sertic Federico, Gregorio Paulo, Chatterjee Shampa, Usman Asad, Broniec Gerald, Bermudez Andres, Richards Thomas, Salas Jonathan, Gray Kathryn, Tschabrunn Cory, Bermudez Christian Andres
Division of Cardiovascular Surgery, Department of Surgery, Hospital of the University of Pennsylvania, University of Pennsylvania, Philadelphia, Pa.
Department of Physiology, University of Pennsylvania School of Medicine, Philadelphia, Pa.
JTCVS Open. 2025 May 4;25:215-224. doi: 10.1016/j.xjon.2025.04.016. eCollection 2025 Jun.
To evaluate the effectiveness of venovenous (VV) extracorporeal membrane oxygenation (ECMO) using a dual-lumen cannula coupled with continuous mechanical chest compressions (cMCC) for cardiopulmonary resuscitation and compare it with venoarterial (VA) ECMO or cMCC only, in a preclinical model.
Twenty-three pigs were allocated into 3 experimental groups: cMCC using a LUCAS 3 compression device, VA-ECMO, and cMCC + VV-ECMO. After cannulation, ventricular fibrillation was induced and circulatory support initiated per allocation. Defibrillation occurred after 30 minutes of support initiation. Hemodynamic, echocardiographic, and laboratory measurements were collected at different timepoints. The primary outcome was the rate of return of spontaneous circulation (ROSC).
ROSC was achieved in 1 of 8 of animals with cMCC only (13%), 5 of 7 (71%) animals with cMCC + VV-ECMO, and 8 of 8 (100%) animals with VA-ECMO. cMCC + VV-ECMO was associated with a significantly greater ROSC rate as compared with compressions alone ( = .04). Arterial oxygen tension was significantly greater with cMCC + VV-ECMO as compared with cMCC alone at all time points. After defibrillation, lactate was lower in the VA-ECMO group as compared with cMCC alone (5.1 mmol/L vs 8.6 mmol/L; < .01) and in the VV-ECMO group (6.3 mmol/L vs 8.6 mmol/L; = .06).
cMCC in association with VV-ECMO using a single dual-lumen femoral cannula may be a viable option of extracorporeal cardiopulmonary resuscitation, potentially leading to greater rates of ROSC when compared with cMCC alone. Additional studies are needed to determine whether this strategy could serve as an early alternative to VA-ECMO in the out-of-hospital cardiac arrest setting.
在临床前模型中,评估使用双腔插管联合持续机械胸外按压(cMCC)的静脉-静脉(VV)体外膜肺氧合(ECMO)用于心肺复苏的有效性,并将其与静脉-动脉(VA)ECMO或仅使用cMCC进行比较。
将23头猪分为3个实验组:使用LUCAS 3按压装置进行cMCC、VA-ECMO和cMCC + VV-ECMO。插管后,诱发心室颤动并根据分组开始循环支持。在支持开始30分钟后进行除颤。在不同时间点收集血流动力学、超声心动图和实验室测量数据。主要结局是自主循环恢复(ROSC)率。
仅使用cMCC的8只动物中有1只(13%)实现了ROSC,cMCC + VV-ECMO的7只动物中有5只(71%)实现了ROSC,VA-ECMO的8只动物中有8只(100%)实现了ROSC。与单独按压相比,cMCC + VV-ECMO的ROSC率显著更高(P = 0.04)。在所有时间点,cMCC + VV-ECMO组的动脉血氧分压均显著高于单独cMCC组。除颤后,VA-ECMO组的乳酸水平低于单独cMCC组(5.1 mmol/L对8.6 mmol/L;P < 0.01)以及VV-ECMO组(6.3 mmol/L对8.6 mmol/L;P = 0.06)。
使用单个双腔股静脉插管进行cMCC联合VV-ECMO可能是体外心肺复苏的一种可行选择,与单独使用cMCC相比,可能导致更高的ROSC率。需要进一步研究以确定该策略是否可作为院外心脏骤停情况下VA-ECMO的早期替代方案。